(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane has been researched along with Psychoses, Drug in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Futatsubashi, M; Iyo, M; Minabe, Y; Mori, N; Nakamura, K; Okada, H; Ouchi, Y; Sekine, Y; Suzuki, K; Takei, N; Tsukada, H; Yoshikawa, E | 1 |
Futatsubashi, M; Iyo, M; Matsunaga, T; Mori, N; Okada, H; Ouchi, Y; Sekine, Y; Takei, N; Tsukada, H; Yoshikawa, E | 1 |
2 other study(ies) available for (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and Psychoses, Drug
Article | Year |
---|---|
Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.
Topics: Adult; Amphetamine-Related Disorders; Amygdala; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Frontal Lobe; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Prefrontal Cortex; Psychoses, Substance-Induced; Tomography, Emission-Computed | 2003 |
Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
Topics: Adult; Behavior, Addictive; Brain Chemistry; Brief Psychiatric Rating Scale; Carbon Radioisotopes; Carrier Proteins; Caudate Nucleus; Cerebellar Cortex; Cocaine; Dopamine Plasma Membrane Transport Proteins; Humans; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Nucleus Accumbens; Prefrontal Cortex; Psychoses, Substance-Induced; Putamen; Substance-Related Disorders; Tomography, Emission-Computed | 2001 |